{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:51:57Z","timestamp":1787003517336,"version":"build-2736575974"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T00:00:00Z","timestamp":1635379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T00:00:00Z","timestamp":1635379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000191","name":"Kidney Foundation of Canada","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000191","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002655","name":"Terry Fox Foundation","doi-asserted-by":"crossref","award":["TFF-166128"],"award-info":[{"award-number":["TFF-166128"]}],"id":[{"id":"10.13039\/501100002655","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002655","name":"Terry Fox Foundation","doi-asserted-by":"crossref","award":["TFF-166128"],"award-info":[{"award-number":["TFF-166128"]}],"id":[{"id":"10.13039\/501100002655","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002655","name":"Terry Fox Foundation","doi-asserted-by":"crossref","award":["TFF-166128"],"award-info":[{"award-number":["TFF-166128"]}],"id":[{"id":"10.13039\/501100002655","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002655","name":"Terry Fox Foundation","doi-asserted-by":"crossref","award":["TFF-166128"],"award-info":[{"award-number":["TFF-166128"]}],"id":[{"id":"10.13039\/501100002655","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002655","name":"Terry Fox Foundation","doi-asserted-by":"crossref","award":["TFF-166128"],"award-info":[{"award-number":["TFF-166128"]}],"id":[{"id":"10.13039\/501100002655","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002655","name":"Terry Fox Foundation","doi-asserted-by":"crossref","award":["TFF-166128"],"award-info":[{"award-number":["TFF-166128"]}],"id":[{"id":"10.13039\/501100002655","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002655","name":"Terry Fox Foundation","doi-asserted-by":"crossref","award":["TFF-166128"],"award-info":[{"award-number":["TFF-166128"]}],"id":[{"id":"10.13039\/501100002655","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002655","name":"Terry Fox Foundation","doi-asserted-by":"crossref","award":["TFF-166128"],"award-info":[{"award-number":["TFF-166128"]}],"id":[{"id":"10.13039\/501100002655","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002655","name":"Terry Fox Foundation","doi-asserted-by":"crossref","award":["TFF-166128"],"award-info":[{"award-number":["TFF-166128"]}],"id":[{"id":"10.13039\/501100002655","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002655","name":"Terry Fox Foundation","doi-asserted-by":"crossref","award":["TFF-166128"],"award-info":[{"award-number":["TFF-166128"]}],"id":[{"id":"10.13039\/501100002655","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002655","name":"Terry Fox Foundation","doi-asserted-by":"crossref","award":["TFF-166128"],"award-info":[{"award-number":["TFF-166128"]}],"id":[{"id":"10.13039\/501100002655","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002655","name":"Terry Fox Foundation","doi-asserted-by":"crossref","award":["TFF-166128"],"award-info":[{"award-number":["TFF-166128"]}],"id":[{"id":"10.13039\/501100002655","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"crossref","award":["PJT-165829"],"award-info":[{"award-number":["PJT-165829"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"crossref","award":["PJT-165829"],"award-info":[{"award-number":["PJT-165829"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"crossref","award":["PJT-165829"],"award-info":[{"award-number":["PJT-165829"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"crossref","award":["PJT-165829"],"award-info":[{"award-number":["PJT-165829"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"crossref","award":["PJT-165829"],"award-info":[{"award-number":["PJT-165829"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"crossref","award":["PJT-165829"],"award-info":[{"award-number":["PJT-165829"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"crossref","award":["PJT-165829"],"award-info":[{"award-number":["PJT-165829"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"crossref","award":["PJT-165829"],"award-info":[{"award-number":["PJT-165829"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"crossref","award":["PJT-165829"],"award-info":[{"award-number":["PJT-165829"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"crossref","award":["PJT-165829"],"award-info":[{"award-number":["PJT-165829"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"crossref","award":["PJT-159530"],"award-info":[{"award-number":["PJT-159530"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"crossref","award":["PJT-165829"],"award-info":[{"award-number":["PJT-165829"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"crossref","award":["PJT-165829"],"award-info":[{"award-number":["PJT-165829"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009326","name":"Cancer Research Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009326","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fonds de recherche du Qu\u00e9bec-Sant\u00e9"},{"name":"Canada Research Chair Program"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Non-alcoholic fatty liver disease (NAFLD) is the most frequent liver disease worldwide and can progress to non-alcoholic steatohepatitis (NASH), which is characterized by triglyceride accumulation, inflammation, and fibrosis. No pharmacological agents are currently approved to treat these conditions, but it is clear now that modulation of lipid synthesis and autophagy are key biological mechanisms that could help reduce or prevent these liver diseases. The folliculin (FLCN) protein has been recently identified as a central regulatory node governing whole body energy homeostasis, and we hypothesized that FLCN regulates highly metabolic tissues like the liver. We thus generated a liver specific\n                    <jats:italic>Flcn<\/jats:italic>\n                    knockout mouse model to study its role in liver disease progression. Using the methionine- and choline-deficient diet to mimic liver fibrosis, we demonstrate that loss of\n                    <jats:italic>Flcn<\/jats:italic>\n                    reduced triglyceride accumulation, fibrosis, and inflammation in mice. In this aggressive liver disease setting, loss of\n                    <jats:italic>Flcn<\/jats:italic>\n                    led to activation of transcription factors TFEB and TFE3 to promote autophagy, promoting the degradation of intracellular lipid stores, ultimately resulting in reduced hepatocellular damage and inflammation. Hence, the activity of FLCN could be a promising target for small molecule drugs to treat liver fibrosis by specifically activating autophagy. Collectively, these results show an unexpected role for\n                    <jats:italic>Flcn<\/jats:italic>\n                    in fatty liver disease progression and highlight new potential treatment strategies.\n                  <\/jats:p>","DOI":"10.1038\/s41598-021-99958-7","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T06:02:44Z","timestamp":1635400964000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Loss of hepatic\u00a0Flcn protects against fibrosis and inflammation by activating autophagy pathways"],"prefix":"10.1038","volume":"11","author":[{"given":"Mathieu","family":"Paquette","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josu\u00e9 M. J.","family":"Ram\u00edrez-Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leeanna","family":"El-Houjeiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Biondini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine R.","family":"Dufour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeonju","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Pacis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Gigu\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Estall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"Siegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9tienne","family":"Audet-Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnim","family":"Pause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,28]]},"reference":[{"key":"99958_CR1","doi-asserted-by":"publisher","unstructured":"European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO). EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease. Obes. Facts. 2016;9:65\u201390. doi:https:\/\/doi.org\/10.1159\/000443344.","DOI":"10.1159\/000443344"},{"key":"99958_CR2","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1146\/annurev-pathol-020117-043617","volume":"13","author":"JP Arab","year":"2018","unstructured":"Arab, J. P., Arrese, M. & Trauner, M. Recent insights into the pathogenesis of nonalcoholic fatty liver disease. Annu. Rev. Pathol. 13, 321\u2013350. https:\/\/doi.org\/10.1146\/annurev-pathol-020117-043617 (2018).","journal-title":"Annu. Rev. Pathol."},{"key":"99958_CR3","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1055\/s-0035-1562943","volume":"35","author":"SK Satapathy","year":"2015","unstructured":"Satapathy, S. K. & Sanyal, A. J. Epidemiology and natural history of nonalcoholic fatty liver disease. Semin. Liver Dis. 35, 221\u2013235. https:\/\/doi.org\/10.1055\/s-0035-1562943 (2015).","journal-title":"Semin. Liver Dis."},{"key":"99958_CR4","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","volume":"149","author":"P Angulo","year":"2015","unstructured":"Angulo, P. et al. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology 149, 389\u201397.e10. https:\/\/doi.org\/10.1053\/j.gastro.2015.04.043 (2015).","journal-title":"Gastroenterology"},{"key":"99958_CR5","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","volume":"70","author":"ZM Younossi","year":"2019","unstructured":"Younossi, Z. M. Non-alcoholic fatty liver disease\u2014A global public health perspective. J. Hepatol. 70, 531\u2013544. https:\/\/doi.org\/10.1016\/j.jhep.2018.10.033 (2019).","journal-title":"J. Hepatol."},{"key":"99958_CR6","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41575-018-0014-9","volume":"15","author":"VW-S Wong","year":"2018","unstructured":"Wong, V.W.-S., Adams, L. A., de L\u00e9dinghen, V., Wong, G.L.-H. & Sookoian, S. Noninvasive biomarkers in NAFLD and NASH - current progress and future promise. Nat. Rev. Gastroenterol. Hepatol. 15, 461\u2013478. https:\/\/doi.org\/10.1038\/s41575-018-0014-9 (2018).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"99958_CR7","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1136\/gutjnl-2017-315691","volume":"67","author":"SH Ibrahim","year":"2018","unstructured":"Ibrahim, S. H., Hirsova, P. & Gores, G. J. Non-alcoholic steatohepatitis pathogenesis: sublethal hepatocyte injury as a driver of liver inflammation. Gut 67, 963\u2013972. https:\/\/doi.org\/10.1136\/gutjnl-2017-315691 (2018).","journal-title":"Gut"},{"key":"99958_CR8","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1053\/j.gastro.2016.02.066","volume":"150","author":"MV Machado","year":"2016","unstructured":"Machado, M. V. & Diehl, A. M. Pathogenesis of nonalcoholic steatohepatitis. Gastroenterology 150, 1769\u20131777. https:\/\/doi.org\/10.1053\/j.gastro.2016.02.066 (2016).","journal-title":"Gastroenterology"},{"key":"99958_CR9","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.3109\/10715762.2015.1078461","volume":"49","author":"NU Ashraf","year":"2015","unstructured":"Ashraf, N. U. & Sheikh, T. A. Endoplasmic reticulum stress and Oxidative stress in the pathogenesis of Non-alcoholic fatty liver disease. Free Radic. Res. 49, 1405\u20131418. https:\/\/doi.org\/10.3109\/10715762.2015.1078461 (2015).","journal-title":"Free Radic. Res."},{"key":"99958_CR10","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1055\/s-0035-1550065","volume":"35","author":"P Angulo","year":"2015","unstructured":"Angulo, P., Machado, M. V. & Diehl, A. M. Fibrosis in nonalcoholic Fatty liver disease: mechanisms and clinical implications. Semin. Liver Dis. 35, 132\u2013145. https:\/\/doi.org\/10.1055\/s-0035-1550065 (2015).","journal-title":"Semin. Liver Dis."},{"key":"99958_CR11","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.mayocp.2013.10.009","volume":"89","author":"MV Machado","year":"2014","unstructured":"Machado, M. V. & Diehl, A. M. Liver renewal: detecting misrepair and optimizing regeneration. Mayo Clin. Proc. 89, 120\u2013130. https:\/\/doi.org\/10.1016\/j.mayocp.2013.10.009 (2014).","journal-title":"Mayo Clin. Proc."},{"key":"99958_CR12","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.tcb.2015.10.013","volume":"26","author":"DG Hardie","year":"2016","unstructured":"Hardie, D. G., Schaffer, B. E. & Brunet, A. AMPK: An Energy-Sensing Pathway with Multiple Inputs and Outputs. Trends Cell Biol. 26, 190\u2013201. https:\/\/doi.org\/10.1016\/j.tcb.2015.10.013 (2016).","journal-title":"Trends Cell Biol."},{"key":"99958_CR13","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1002\/hep.29849","volume":"68","author":"H Chen","year":"2018","unstructured":"Chen, H. et al. DEP domain-containing mTOR-interacting protein suppresses lipogenesis and ameliorates hepatic steatosis and acute-on-chronic liver injury in alcoholic liver disease. Hepatology 68, 496\u2013514. https:\/\/doi.org\/10.1002\/hep.29849 (2018).","journal-title":"Hepatology"},{"key":"99958_CR14","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.jhep.2013.01.011","volume":"58","author":"C-W Lin","year":"2013","unstructured":"Lin, C.-W. et al. Pharmacological promotion of autophagy alleviates steatosis and injury in alcoholic and non-alcoholic fatty liver conditions in mice. J. Hepatol. 58, 993\u2013999. https:\/\/doi.org\/10.1016\/j.jhep.2013.01.011 (2013).","journal-title":"J. Hepatol."},{"key":"99958_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers10010018","volume":"10","author":"M Paquette","year":"2018","unstructured":"Paquette, M., El-Houjeiri, L. & Pause, A. mTOR Pathways in Cancer and Autophagy. Cancers (Basel) 10, 1. https:\/\/doi.org\/10.3390\/cancers10010018 (2018).","journal-title":"Cancers (Basel)"},{"key":"99958_CR16","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1080\/15548627.2020.1797288","volume":"16","author":"A He","year":"2020","unstructured":"He, A., Dean, J. M., Lu, D., Chen, Y. & Lodhi, I. J. Hepatic peroxisomal \u03b2-oxidation suppresses lipophagy via RPTOR acetylation and MTOR activation. Autophagy 16, 1727\u20131728. https:\/\/doi.org\/10.1080\/15548627.2020.1797288 (2020).","journal-title":"Autophagy"},{"key":"99958_CR17","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.cmet.2014.05.001","volume":"20","author":"A Umemura","year":"2014","unstructured":"Umemura, A. et al. Liver damage, inflammation, and enhanced tumorigenesis after persistent mTORC1 inhibition. Cell Metab 20, 133\u2013144. https:\/\/doi.org\/10.1016\/j.cmet.2014.05.001 (2014).","journal-title":"Cell Metab"},{"key":"99958_CR18","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1002\/cam4.150","volume":"2","author":"K Yamanaka","year":"2013","unstructured":"Yamanaka, K. et al. Therapeutic potential and adverse events of everolimus for treatment of hepatocellular carcinoma - systematic review and meta-analysis. Cancer Med 2, 862\u2013871. https:\/\/doi.org\/10.1002\/cam4.150 (2013).","journal-title":"Cancer Med"},{"key":"99958_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004273","volume":"10","author":"E Possik","year":"2014","unstructured":"Possik, E. et al. Folliculin regulates ampk-dependent autophagy and metabolic stress survival. PLoS Genet. 10, e1004273. https:\/\/doi.org\/10.1371\/journal.pgen.1004273 (2014).","journal-title":"PLoS Genet."},{"key":"99958_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1005520","volume":"11","author":"E Possik","year":"2015","unstructured":"Possik, E. et al. FLCN and AMPK confer resistance to hyperosmotic stress via remodeling of glycogen stores. PLoS Genet. 11, e1005520. https:\/\/doi.org\/10.1371\/journal.pgen.1005520 (2015).","journal-title":"PLoS Genet."},{"key":"99958_CR21","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1093\/jnci\/djs418","volume":"104","author":"H Hasumi","year":"2012","unstructured":"Hasumi, H. et al. Regulation of mitochondrial oxidative metabolism by tumor suppressor FLCN. J Natl. Cancer Inst. 104, 1750\u20131764. https:\/\/doi.org\/10.1093\/jnci\/djs418 (2012).","journal-title":"J Natl. Cancer Inst."},{"key":"99958_CR22","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1101\/gad.281410.116","volume":"30","author":"M Yan","year":"2016","unstructured":"Yan, M. et al. Chronic AMPK activation via loss of FLCN induces functional beige adipose tissue through PGC-1\u03b1\/ERR\u03b1. Genes Dev. 30, 1034\u20131046. https:\/\/doi.org\/10.1101\/gad.281410.116 (2016).","journal-title":"Genes Dev."},{"key":"99958_CR23","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1101\/gad.287953.116","volume":"30","author":"S Wada","year":"2016","unstructured":"Wada, S. et al. The tumor suppressor FLCN mediates an alternate mTOR pathway to regulate browning of adipose tissue. Genes Dev. 30, 2551\u20132564. https:\/\/doi.org\/10.1101\/gad.287953.116 (2016).","journal-title":"Genes Dev."},{"key":"99958_CR24","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1083\/jcb.201712177","volume":"217","author":"J Meng","year":"2018","unstructured":"Meng, J. & Ferguson, S. M. GATOR1-dependent recruitment of FLCN-FNIP to lysosomes coordinates Rag GTPase heterodimer nucleotide status in response to amino acids. J. Cell Biol. 217, 2765\u20132776. https:\/\/doi.org\/10.1083\/jcb.201712177 (2018).","journal-title":"J. Cell Biol."},{"key":"99958_CR25","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.molcel.2013.09.016","volume":"52","author":"Z-Y Tsun","year":"2013","unstructured":"Tsun, Z.-Y. et al. The folliculin tumor suppressor is a GAP for the RagC\/D GTPases that signal amino acid levels to mTORC1. Mol. Cell 52, 495\u2013505. https:\/\/doi.org\/10.1016\/j.molcel.2013.09.016 (2013).","journal-title":"Mol. Cell"},{"key":"99958_CR26","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41586-020-2444-0","volume":"585","author":"G Napolitano","year":"2020","unstructured":"Napolitano, G. et al. A substrate-specific mTORC1 pathway underlies Birt-Hogg-Dub\u00e9 syndrome. Nature 585, 597\u2013602. https:\/\/doi.org\/10.1038\/s41586-020-2444-0 (2020).","journal-title":"Nature"},{"key":"99958_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nu9101072","volume":"9","author":"MA Van Herck","year":"2017","unstructured":"Van Herck, M. A., Vonghia, L. & Francque, S. M. Animal models of nonalcoholic fatty liver disease\u2014A Starter\u2019s guide. Nutrients 9, 1. https:\/\/doi.org\/10.3390\/nu9101072 (2017).","journal-title":"Nutrients"},{"key":"99958_CR28","first-page":"2683","volume":"6","author":"H Itagaki","year":"2013","unstructured":"Itagaki, H., Shimizu, K., Morikawa, S., Ogawa, K. & Ezaki, T. Morphological and functional characterization of non-alcoholic fatty liver disease induced by a methionine-choline-deficient diet in C57BL\/6 mice. Int. J. Clin. Exp. Pathol. 6, 2683\u20132696 (2013).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"99958_CR29","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s12072-020-10066-6","volume":"14","author":"MJ Caldez","year":"2020","unstructured":"Caldez, M. J., Bjorklund, M. & Kaldis, P. Cell cycle regulation in NAFLD: when imbalanced metabolism limits cell division. Hepatol. Int. 14, 463\u2013474. https:\/\/doi.org\/10.1007\/s12072-020-10066-6 (2020).","journal-title":"Hepatol. Int."},{"key":"99958_CR30","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1126\/science.1174447","volume":"325","author":"M Sardiello","year":"2009","unstructured":"Sardiello, M. et al. A gene network regulating lysosomal biogenesis and function. Science 325, 473\u2013477. https:\/\/doi.org\/10.1126\/science.1174447 (2009).","journal-title":"Science"},{"key":"99958_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015793","volume":"5","author":"S-B Hong","year":"2010","unstructured":"Hong, S.-B. et al. Inactivation of the FLCN tumor suppressor gene induces TFE3 transcriptional activity by increasing its nuclear localization. PLoS ONE 5, e15793. https:\/\/doi.org\/10.1371\/journal.pone.0015793 (2010).","journal-title":"PLoS ONE"},{"key":"99958_CR32","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.1016\/j.celrep.2019.02.102","volume":"26","author":"L El-Houjeiri","year":"2019","unstructured":"El-Houjeiri, L. et al. The Transcription Factors TFEB and TFE3 Link the FLCN-AMPK Signaling Axis to Innate Immune Response and Pathogen Resistance. Cell Rep. 26, 3613-3628.e6. https:\/\/doi.org\/10.1016\/j.celrep.2019.02.102 (2019).","journal-title":"Cell Rep."},{"key":"99958_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/jci.insight.126939","volume":"5","author":"J Li","year":"2019","unstructured":"Li, J. et al. Myeloid Folliculin balances mTOR activation to maintain innate immunity homeostasis. JCI Insight 5, 1. https:\/\/doi.org\/10.1172\/jci.insight.126939 (2019).","journal-title":"JCI Insight"},{"key":"99958_CR34","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.4049\/jimmunol.1001954","volume":"186","author":"H-M Lee","year":"2011","unstructured":"Lee, H.-M. et al. Autophagy negatively regulates keratinocyte inflammatory responses via scaffolding protein p62\/SQSTM1. J. Immunol. 186, 1248\u20131258. https:\/\/doi.org\/10.4049\/jimmunol.1001954 (2011).","journal-title":"J. Immunol."},{"key":"99958_CR35","doi-asserted-by":"publisher","first-page":"S108","DOI":"10.1016\/j.exphem.2017.06.267","volume":"53","author":"M Endo","year":"2017","unstructured":"Endo, M. et al. The FLCN-TFE3 axis regulates macrophage activation through cellular metabolism. Exp. Hematol. 53, S108\u2013S109. https:\/\/doi.org\/10.1016\/j.exphem.2017.06.267 (2017).","journal-title":"Exp. Hematol."},{"key":"99958_CR36","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1016\/j.celrep.2020.01.042","volume":"30","author":"M Endoh","year":"2020","unstructured":"Endoh, M. et al. A FLCN-TFE3 feedback loop prevents excessive glycogenesis and phagocyte activation by regulating lysosome activity. Cell Rep. 30, 1823-1834.e5. https:\/\/doi.org\/10.1016\/j.celrep.2020.01.042 (2020).","journal-title":"Cell Rep."},{"key":"99958_CR37","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1016\/j.bbrc.2018.07.094","volume":"503","author":"J Zeng","year":"2018","unstructured":"Zeng, J., Zhu, B. & Su, M. Autophagy is involved in acetylshikonin ameliorating non-alcoholic steatohepatitis through AMPK\/mTOR pathway. Biochem. Biophys. Res. Commun. 503, 1645\u20131650. https:\/\/doi.org\/10.1016\/j.bbrc.2018.07.094 (2018).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"99958_CR38","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12944-015-0139-6","volume":"14","author":"G Ji","year":"2015","unstructured":"Ji, G., Wang, Y., Deng, Y., Li, X. & Jiang, Z. Resveratrol ameliorates hepatic steatosis and inflammation in methionine\/choline-deficient diet-induced steatohepatitis through regulating autophagy. Lipids Health Dis. 14, 134. https:\/\/doi.org\/10.1186\/s12944-015-0139-6 (2015).","journal-title":"Lipids Health Dis."},{"key":"99958_CR39","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ejphar.2015.11.012","volume":"770","author":"R Chen","year":"2016","unstructured":"Chen, R. et al. Protective role of autophagy in methionine-choline deficient diet-induced advanced nonalcoholic steatohepatitis in mice. Eur. J. Pharmacol. 770, 126\u2013133. https:\/\/doi.org\/10.1016\/j.ejphar.2015.11.012 (2016).","journal-title":"Eur. J. Pharmacol."},{"key":"99958_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15548627.2020.1834711","volume":"1","author":"H-S Park","year":"2020","unstructured":"Park, H.-S. et al. TXNIP\/VDUP1 attenuates steatohepatitis via autophagy and fatty acid oxidation. Autophagy 1, 1\u201316. https:\/\/doi.org\/10.1080\/15548627.2020.1834711 (2020).","journal-title":"Autophagy"},{"key":"99958_CR41","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/j.cell.2019.10.036","volume":"179","author":"K Shen","year":"2019","unstructured":"Shen, K. et al. Cryo-EM Structure of the Human FLCN-FNIP2-Rag-Ragulator Complex. Cell 179, 1319-1329.e8. https:\/\/doi.org\/10.1016\/j.cell.2019.10.036 (2019).","journal-title":"Cell"},{"key":"99958_CR42","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1126\/science.aax0364","volume":"366","author":"RE Lawrence","year":"2019","unstructured":"Lawrence, R. E. et al. Structural mechanism of a Rag GTPase activation checkpoint by the lysosomal folliculin complex. Science 366, 971\u2013977. https:\/\/doi.org\/10.1126\/science.aax0364 (2019).","journal-title":"Science"},{"key":"99958_CR43","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114\u20132120. https:\/\/doi.org\/10.1093\/bioinformatics\/btu170 (2014).","journal-title":"Bioinformatics"},{"key":"99958_CR44","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321. https:\/\/doi.org\/10.1093\/bioinformatics\/bts635 (2013).","journal-title":"Bioinformatics"},{"key":"99958_CR45","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","volume":"31","author":"S Anders","year":"2015","unstructured":"Anders, S., Pyl, P. T. & Huber, W. HTSeq \u2014 A Python framework to work with high-throughput sequencing data. Bioinformatics 31, 166\u2013169. https:\/\/doi.org\/10.1093\/bioinformatics\/btu638 (2015).","journal-title":"Bioinformatics"},{"key":"99958_CR46","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 43, e47. https:\/\/doi.org\/10.1093\/nar\/gkv007 (2015).","journal-title":"Nucleic Acids Res"},{"key":"99958_CR47","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov, M. V. et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res 44, W90\u2013W97. https:\/\/doi.org\/10.1093\/nar\/gkw377 (2016).","journal-title":"Nucleic Acids Res"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-99958-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-99958-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-99958-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T12:03:57Z","timestamp":1670069037000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-99958-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,28]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["99958"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-99958-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,28]]},"assertion":[{"value":"1 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21268"}}